Chugai Pharmaceutical Co., Ltd. (CHGCF)
USD 43.95
(44.76%)
USD 43.95
(44.76%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 197.80 JPY | -13.1% |
| 2022 | 227.64 JPY | 23.52% |
| 2021 | 184.29 JPY | 41.05% |
| 2020 | 130.66 JPY | 36.18% |
| 2019 | 95.95 JPY | 70.37% |
| 2018 | 56.32 JPY | 26.99% |
| 2017 | 44.35 JPY | 35.59% |
| 2016 | 32.71 JPY | -12.38% |
| 2015 | 37.33 JPY | 19.72% |
| 2014 | 31.18 JPY | 0.06% |
| 2013 | 31.16 JPY | 10.46% |
| 2012 | 28.21 JPY | 30.72% |
| 2011 | 21.58 JPY | -14.97% |
| 2010 | 25.38 JPY | -26.8% |
| 2009 | 34.67 JPY | 44.34% |
| 2008 | 24.02 JPY | -1.6% |
| 2007 | 24.41 JPY | 6.5% |
| 2006 | 22.92 JPY | -28.38% |
| 2005 | 32.00 JPY | 56.17% |
| 2004 | 20.49 JPY | 18.99% |
| 2003 | 17.22 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 45.22 JPY | -18.42% |
| 2024 Q2 | 67.98 JPY | 50.31% |
| 2023 Q3 | 47.15 JPY | -6.76% |
| 2023 Q4 | 55.43 JPY | 17.56% |
| 2023 Q1 | 44.68 JPY | -28.28% |
| 2023 FY | - JPY | -13.1% |
| 2023 Q2 | 50.57 JPY | 13.18% |
| 2022 Q4 | 62.30 JPY | 51.18% |
| 2022 Q2 | 44.00 JPY | -45.1% |
| 2022 Q1 | 80.14 JPY | 33.32% |
| 2022 FY | - JPY | 23.52% |
| 2022 Q3 | 41.21 JPY | -6.34% |
| 2021 Q2 | 43.02 JPY | 49.17% |
| 2021 Q1 | 28.84 JPY | -9.37% |
| 2021 FY | - JPY | 41.05% |
| 2021 Q4 | 60.11 JPY | 14.91% |
| 2021 Q3 | 52.31 JPY | 21.59% |
| 2020 Q1 | 31.37 JPY | 28.3% |
| 2020 Q3 | 36.58 JPY | 18.42% |
| 2020 FY | - JPY | 36.18% |
| 2020 Q4 | 31.82 JPY | -13.01% |
| 2020 Q2 | 30.89 JPY | -1.53% |
| 2019 Q3 | 29.31 JPY | 40.64% |
| 2019 Q2 | 20.84 JPY | -2.34% |
| 2019 FY | - JPY | 70.37% |
| 2019 Q1 | 21.34 JPY | 57.84% |
| 2019 Q4 | 24.45 JPY | -16.58% |
| 2018 Q3 | 13.20 JPY | 4.18% |
| 2018 Q4 | 13.52 JPY | 2.42% |
| 2018 Q2 | 12.67 JPY | -25.47% |
| 2018 Q1 | 17.00 JPY | 79.51% |
| 2018 FY | - JPY | 26.99% |
| 2017 Q4 | 9.47 JPY | -26.36% |
| 2017 Q2 | 10.73 JPY | -4.96% |
| 2017 Q1 | 11.29 JPY | 75.86% |
| 2017 FY | - JPY | 35.59% |
| 2017 Q3 | 12.86 JPY | 19.85% |
| 2016 FY | - JPY | -12.38% |
| 2016 Q3 | 7.04 JPY | -32.37% |
| 2016 Q2 | 10.41 JPY | 17.63% |
| 2016 Q1 | 8.85 JPY | 7.66% |
| 2016 Q4 | 6.42 JPY | -8.81% |
| 2015 FY | - JPY | 19.72% |
| 2015 Q4 | 8.22 JPY | -23.11% |
| 2015 Q3 | 10.69 JPY | 12.53% |
| 2015 Q2 | 9.50 JPY | 6.62% |
| 2015 Q1 | 8.91 JPY | 30.07% |
| 2014 Q3 | 6.62 JPY | 6.95% |
| 2014 Q4 | 6.85 JPY | 3.47% |
| 2014 FY | - JPY | 0.06% |
| 2014 Q1 | 11.49 JPY | 47.12% |
| 2014 Q2 | 6.19 JPY | -46.13% |
| 2013 Q4 | 7.81 JPY | -4.87% |
| 2013 Q3 | 8.21 JPY | -15.36% |
| 2013 FY | - JPY | 10.46% |
| 2013 Q1 | 5.45 JPY | -51.56% |
| 2013 Q2 | 9.70 JPY | 77.98% |
| 2012 FY | - JPY | 30.72% |
| 2012 Q1 | 6.56 JPY | 32.26% |
| 2012 Q4 | 11.25 JPY | 101.61% |
| 2012 Q3 | 5.58 JPY | -16.59% |
| 2012 Q2 | 6.69 JPY | 1.98% |
| 2011 Q4 | 4.96 JPY | -19.35% |
| 2011 FY | - JPY | -14.97% |
| 2011 Q3 | 6.15 JPY | -17.0% |
| 2011 Q1 | 3.06 JPY | -62.68% |
| 2011 Q2 | 7.41 JPY | 142.16% |
| 2010 Q4 | 8.20 JPY | 14.69% |
| 2010 Q2 | 5.22 JPY | 8.52% |
| 2010 Q1 | 4.81 JPY | -50.1% |
| 2010 FY | - JPY | -26.8% |
| 2010 Q3 | 7.15 JPY | 36.97% |
| 2009 Q1 | 8.20 JPY | 0.0% |
| 2009 Q3 | 8.69 JPY | 16.33% |
| 2009 Q4 | 9.64 JPY | 10.93% |
| 2009 FY | - JPY | 44.34% |
| 2009 Q2 | 7.47 JPY | -8.9% |
| 2008 FY | - JPY | -1.6% |
| 2007 FY | - JPY | 6.5% |
| 2006 FY | - JPY | -28.38% |
| 2005 FY | - JPY | 56.17% |
| 2004 FY | - JPY | 18.99% |
| 2003 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AstraZeneca PLC | 3.84 USD | -5051.042% |
| Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | -4997.938% |
| CSPC Pharmaceutical Group Limited | 0.07 USD | -282471.429% |
| Clarus Therapeutics Holdings, Inc. | -8.04 USD | 2560.199% |
| Novartis AG | 7.63 USD | -2492.398% |
| PT Kalbe Farma Tbk. | 0.00 USD | -5071694.872% |